SNAI2 and breast carcinoma: -Inhibited mesenchymal phenotypes of basal type breast cancer cells through downregulation of SLUG-Decreased SLUG through inhibition of PI3K/AKT and RAS/RAF-1/ERK signaling-Suppressed the metastatic ability of breast cancer cells to lungs